Vrajová M, Peková S, Horácek J, Höschl C.
Journal Article 2011; 32(3): 246-252 PubMed PMID: 21712773 Keywords: Brain-Derived Neurotrophic Factor:genetics, Cell Line, Cells, Cultured, Down-Regulation, Gene Expression Profiling, Gene Silencing, Genome, Human:genetics, Histones:genetics, Humans, Microarray Analysis, Nerve Tissue Proteins:genetics, Neurons:drug effect. CitationOBJECTIVE: The regulator of G-protein signaling (RGS) molecules represent a class of proteins that modulate the signaling activity of G-pr.....
Vrajová M, Peková S, Horácek J, Höschl C. The effects of siRNA-mediated RGS4 gene silencing on the whole genome transcription profile: implications for schizophrenia. Neuro Endocrinol Lett. 2011 Jan; 32(3): 246-252
Zavesicka L, Brunovsky M, Horacek J, Matousek M, Sos P, Krajca V, Höschl C.
Comparative Study 2008; 29(6): 895-901 PubMed PMID: 19112384 Keywords: Adult, Antidepressive Agents, Second-Generation:therapeutic use, Cognitive Therapy:methods, Combined Modality Therapy, Female, Humans, Hypnotics and Sedatives:therapeutic use, Male, Middle Aged, Polysomnography, Sleep Initiation and Maintenance Disorders:. CitationOBJECTIVES: Cognitive behaviour therapy (CBT) of primary insomnia is frequently combined with various pharmacological treatments, includin.....
Zavesicka L, Brunovsky M, Horacek J, Matousek M, Sos P, Krajca V, Höschl C. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett. 2008 Dec; 29(6): 895-901
Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, Höschl C.
Controlled Clinical Trial 2006; 27(5): 587-594 PubMed PMID: 17159818 Keywords: Adolescent, Adult, Basal Metabolism, Brain:metabolism, Brain Mapping, Female, Fluorodeoxyglucose F18:metabolism, Frontal Lobe:metabolism, Humans, Male, Middle Aged, Positron-Emission Tomography:methods, Psychomotor Performance, Schizophrenia:metabolism, T. CitationOBJECTIVES: With the aim to indicate the functional anatomical substrate of cognitive dysfunction in schizophrenia we evaluated the relati.....
Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, Höschl C. Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Neuro Endocrinol Lett. 2006 Oct; 27(5): 587-594
Prasko J, Dockery C, Horácek J, Houbová P, Kosová J, Klaschka J, Pasková B, Praskova H, Seifertová D, Záleský R, Höschl C.
Journal Article 2006; 27(4): 473-481 PubMed PMID: 16891998 Keywords: Adolescent, Adult, Anxiety:drug therapy, Cognitive Therapy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Moclobemide:therapeutic use, Monoamine Oxidase Inhibitors:therapeutic use, Patient Dropouts, Phobic Disorders:drug. Citation: The aim of the study was to assess the 6-months treatment efficacy and 24-month follow up of three different therapeutic programs (A. mo.....
Prasko J, Dockery C, Horácek J, Houbová P, Kosová J, Klaschka J, Pasková B, Praskova H, Seifertová D, Záleský R, Höschl C. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuro Endocrinol Lett. 2006 Aug; 27(4): 473-481
Novák T, Horácek J, Mohr P, Kopecek M, Skrdlantová L, Klirova M, Rodriguez M, Spaniel F, Dockery C, Höschl C.
Journal Article 2006; 27(1-2): 209-213 PubMed PMID: 16648775 Keywords: Adult, Double-Blind Method, Female, Humans, Male, Neuropsychological Tests, Psychiatric Status Rating Scales, Schizophrenia:therapy, Schizophrenic Psychology, Transcranial Magnetic Stimulation,. Citation: The high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the prefrontal cortex is a promising method for the treat.....
Novák T, Horácek J, Mohr P, Kopecek M, Skrdlantová L, Klirova M, Rodriguez M, Spaniel F, Dockery C, Höschl C. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett. 2006 Apr; 27(1-2): 209-213
Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C.
Clinical Trial 2004; 25(5): 340-348 PubMed PMID: 15580167 Keywords: Adult, Antidepressive Agents:therapeutic use, Brain Mapping, Cerebral Cortex:diagnostic imaging, Cognitive Therapy, Female, Fluorodeoxyglucose F18, Functional Laterality, Humans, Male, Neuropsychological Tests, Panic Disorder:diagnostic imaging, Positron-. CitationBACKGROUND: The goal of our study was to identify brain structures in patients with panic disorder (PD) that show changes in 18FDG PET dur.....
Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett. 2004 Oct; 25(5): 340-348